Test Price
2,800 AED✅ Home Collection Available
ALG3-Congenital Disorder of Glycosylation Type Id (CDG-Id) Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
This genetic test uses next-generation sequencing to detect pathogenic variants in the ALG3 gene, confirming or excluding Congenital Disorder of Glycosylation Type Id (CDG-Id). The analysis achieves 99.9% diagnostic sensitivity through ISO-accredited processing and includes post-test telephonic guidance by a consultant medical geneticist. Home sample collection is available daily from 8 AM to 11 PM via temperature-controlled cold-chain courier. Insurance billing verification is provided via WhatsApp.
Test Overview & Methodology
What is the ALG3-CDG Genetic Test?
This test analyses the entire coding region of the ALG3 gene to identify pathogenic variants causing Congenital Disorder of Glycosylation Type Id (CDG-Id), a rare inherited metabolic condition. The test uses next-generation sequencing (NGS) to detect single nucleotide variants, small insertions/deletions, and larger copy-number changes across the full gene, providing a comprehensive molecular diagnosis for families with suspected CDG-Id. Results must be interpreted by a qualified geneticist alongside the patient's full clinical picture.
| Feature | Our NGS Test (Full Gene Sequencing) | Alternative (Targeted Sanger) |
|---|---|---|
| Technology | Next‑Generation Sequencing (full gene with CNV analysis) | Sanger sequencing (selected exons only) |
| Detection Power | 99.9% – includes deep intronic & copy‑number variants | ~85% – misses large deletions/duplications |
| Turnaround Time | 3–4 Weeks (ISO 9001 accredited lab) | 6–8 Weeks |
| DHA Compliance | Full – genetic counselling included, PDPL compliant | Often not mandated |
Physician Insight & Safety Protocols
“The ALG3 genetic test provides critical diagnostic clarity for families facing a rare metabolic disorder. It must be interpreted within the full clinical context by a metabolic specialist. While the molecular result is definitive for the specific gene, it does not replace a comprehensive clinical evaluation. I encourage all patients to review their results with their genetic counsellor before making any medical decisions.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Advisory
⚠️ MEDICATION NOTICE: Do not discontinue or alter any prescribed medication without direct consultation with your treating doctor. The results of this genetic test are for diagnostic purposes and should not be used as a sole basis for medication changes.
Exclusion Criteria & Red Flags
- Absolute Exclusions: Known coagulopathy (e.g., haemophilia), active infection at venipuncture site, inability to provide informed consent.
- Relative Cautions: High‑risk pregnancy, extreme needle phobia – please discuss with our medical team.
- Post‑Sample Emergency: If you experience dizziness, vision changes, severe headache, or loss of consciousness after blood draw, proceed to the nearest emergency department immediately.
- For FTA card collection (finger-prick dried blood spot), no exclusions apply – a simple finger-prick is sufficient and does not require venous access.
Patient FAQ & Clinical Guidance
1. What does the ALG3 Genetic Test detect?
This test uses next-generation sequencing to detect ALG3 gene mutations causing Congenital Disorder of Glycosylation Type Id. It screens single nucleotide variants, small insertions/deletions, and larger copy-number changes across the whole coding region, providing a comprehensive molecular diagnosis for families with suspected CDG-Id.
2. How is the sample collected for this genetic test?
A simple blood draw (whole blood in EDTA tube) or finger-prick FTA card sample is collected by a certified phlebotomist. Our team follows temperature-controlled cold-chain logistics for whole blood or extracted DNA, ensuring sample stability from your doorstep to the ISO 9001 laboratory. Home collection is available daily from 8 AM to 11 PM.
3. How long until I receive the results and what do they mean?
Official results are delivered in 3–4 weeks alongside a comprehensive report that must be interpreted by your geneticist. The report details pathogenicity of variants, carrier status implications, and specific clinical recommendations. A post-test teleconsultation with a consultant medical geneticist is included in the service.
UAE Regulatory & Data Privacy Adherence
- Genetic testing is performed under Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety and informed consent protocols.
- All patient data is processed and stored in UAE-hosted secure servers in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139) operating under DHA Facility License No. 1143.
- Test carried out at premises licensed by Dubai Healthcare City Authority – Regulatory (DHCR).
Clinical & Logistical Metadata
| Test Name | ALG3-Congenital Disorder of Glycosylation Type Id (CDG-Id) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks (ISO 9001 accredited lab) |
| Sample Type / Matrix | Whole Blood (EDTA) or FTA Card Dried Blood Spot – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene coding region including CNV detection |
| ICD-10-CM Code | E74.89, Z13.79, Z14.9 |
| LOINC Code | 77637-8 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians